Cardiovascular medication :: Consumers survey results of 2019

Consumers survey results of 2019 in category

Circulatory system / Cardiovascular medication

The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.

	I quarter (january—march)
	II quarter (april—june)
	III quarter (july—september)
	IV quarter (october—december)

1.		Корвалмент (Київський вітамінний завод)	23.02%	5

2.		Кардіомагніл (Nycomed)	20.14%	4.64

3.	4	Корвалтаб (Фарма Старт)	19.42%	4.44

4.	3	Aspirin cardio (Bayer)	15.83%	3.77

5.	10	Валідол (Лубнифарм)	14.39%	3.32

6.	5	Mildronat (Grindex)	12.95%	3.17

7.	14	Validol (Farmak)	10.79%	2.70

8.	23	Глоду настоянка (Лубнифарм)	9.35%	2.46

9.		Валідол-Дарниця (Darnitsa)	10.79%	2.43

10.	11	Трикардин (Ternopharm)	9.35%	2.39

11.	8	Аспаркам (Arterium Corporation)	9.35%	2.30

12.	15	Вітрум кардіо / Вітрум кардіо Омега-3 (Такеда)	10.07%	2.27

13.	19	АТФ-Лонг (Борщагівський ХФЗ)	7.91%	2.25

14.	25	Пумпан (Perrigo)	8.63%	2.16

15.	13	Беліса (Vishpha \| Фармацевтична фабрика Vishpha)	7.19%	2.11

15.	21	Глоду настоянка (Ternopharm)	6.47%	2.11

17.	7	Панангін (Gedeon Richter)	9.35%	1.99

18.	12	Нітрогліцерин (Технолог)	8.63%	1.94

19.	6	Кратал (Борщагівський ХФЗ)	7.19%	1.91

20.		Карвалол-Дарница (Darnitsa)	7.19%	1.78

21.	20	АТФ-Лонг (Фаркос)	6.47%	1.77

22.	29	Неокардил (Валартін Фарма)	6.47%	1.69

23.	17	Краплі Зеленіна (Фітофарм)	4.32%	1.34

24.	27	Кралонін (Heel)	2.16%	0.71

25.	31	Хомвіокорин-N (Homviora Arzneimittel)	2.16%	0.53

25.	22	Хомвіотензин (Homviora Arzneimittel)	2.16%	0.53

27.	18	Кверцетин (Борщагівський ХФЗ)	1.44%	0.34

28.		Кардио-гран (Національна гомеопатична спілка)	0.72%	0.29

28.	30	Ритмокор (Фаркос)	1.44%	0.29

30.	26	Екорін (USV Limited)	1.44%	0.245

31.	24	Кардіплант (Schwabe)	0.72%	0.238

32.	16	Лоспірин (Kusum Pharm)	0.72%	0.143

–.		Акард (Polpharma S.A.)	0.00%	0

–.		Годасал (PRO.MED.CS Praha a.s.)	0.00%	0

The participant which took the 1st place in this rating is by opinion of Ukrainian consumers is the best choice in 2019, recommendation of consumers #1 in the category “Cardiovascular medication”.

Using this rating is only possible with obligatory link to the source.

This rating was built as a result of the study of social preferences in 2019, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media.

Advanced reporting booklet about the study, including demographics of the respondents, by regional breakdown, information roll-call of ad hoc judges etc, can also be obtained from managers of the contest.